Tom Gräfenhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tom Gräfenhan has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Thorsten Bischler
University of Würzburg, Core Unit Systems Medicine, Würzburg, Germany
3 shared publications Annemarie Sodmann
Department of Neurology, University Hospital Würzburg, Würzburg, Germany
2 shared publicationsFelicitas Schlott
2 shared publications- Robert Blum
Department of Neurology, University Hospital Würzburg, Würzburg, Germany
2 shared publications - Alexander Brack1 shared publication
Alyssia Robinson
National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, R3E 3R2, Canada
1 shared publication
Latest Publications
- Open Access
Interdependent mode of RNA recognition by the interacting KH-domain proteins KhpA and KhpB
RNA-binding proteins (RBPs) are central regulators of gene expression. In bacteria, two KH domain-containing proteins, KhpA and KhpB, are increasingly recognized as globally-acting RBPs, including in pathogens that lack well-studied RBPs, such as Hfq and ProQ. While KhpA and KhpB interact with various RNAs in diverse bacteria, their crosstalk and molecular basis of RNA recognition remain poorly understood. Here, we explored the mutual dependence between KhpA and KhpB in the food-borne pathogen Campylobacter jejuni . We demonstrate KhpA and KhpB interact in vivo , and their individual global RNA recognition is largely dependent on the presence of the partner protein. Using RNA co-immunoprecipitation, we reveal that KhpA requires a conserved KH-domain motif for RNA binding, whereas KhpB relies on an atypical R3H domain. Moreover, mutating the RNA-binding domain of one protein compromises the RNA interactome of the other. Overall, we demonstrate an interdependent RNA-binding mode of KhpA and KhpB and anticipate that such KH-proteins have co-evolved to elicit joint RNA regulation in bacteria.
Open AccessInterdependent mode of RNA recognition by the interacting KH-domain proteins KhpA and KhpB
RNA-binding proteins (RBPs) are central regulators of gene expression. In bacteria, two KH domain-containing proteins, KhpA and KhpB, are increasingly recognized as globally-acting RBPs, including in pathogens that lack well-studied RBPs, such as Hfq and ProQ. While KhpA and KhpB interact with various RNAs in diverse bacteria, their crosstalk and molecular basis of RNA recognition remain poorly understood. Here, we explored the mutual dependence between KhpA and KhpB in the food-borne pathogen Campylobacter jejuni . We demonstrate KhpA and KhpB interact in vivo , and their individual global RNA recognition is largely dependent on the presence of the partner protein. Using RNA co-immunoprecipitation, we reveal that KhpA requires a conserved KH-domain motif for RNA binding, whereas KhpB relies on an atypical R3H domain. Moreover, mutating the RNA-binding domain of one protein compromises the RNA interactome of the other. Overall, we demonstrate an interdependent RNA-binding mode of KhpA and KhpB and anticipate that such KH-proteins have co-evolved to elicit joint RNA regulation in bacteria.
- Open Access
- 28 September 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 1273
Culture and gene expression profiling of Schwann cells from human sural nerve
Polyneuropathies (PNP) are diseases of the peripheral nervous system (PNS) whose pathophysiology remains poorly understood. Schwann cells (SC) are the principle glial cells in the PNS, and their dysfunction can lead to demyelination and secondary axonal degeneration, causing or exacerbating PNP. The study of SC can thus shed light on the molecular and cellular mechanisms involved in PNP. Protocols have been developed to isolate and culture human and animal SC from large amounts of starting material. The isolation of human SC from patients, where only small biosamples are available, remains a challenge. In this study, we present a protocol to culture human SC from ~4-mm diagnostic sural nerve biopsies and a comprehensive transcriptome analysis to characterize their phenotype. Our protocol allows the reproducible establishment of cultures containing proliferative human Schwann cells that can be stored, expanded, and used as tools for diagnostic applications.
- 28 September 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1) , 1273
Open AccessCulture and gene expression profiling of Schwann cells from human sural nerve
Polyneuropathies (PNP) are diseases of the peripheral nervous system (PNS) whose pathophysiology remains poorly understood. Schwann cells (SC) are the principle glial cells in the PNS, and their dysfunction can lead to demyelination and secondary axonal degeneration, causing or exacerbating PNP. The study of SC can thus shed light on the molecular and cellular mechanisms involved in PNP. Protocols have been developed to isolate and culture human and animal SC from large amounts of starting material. The isolation of human SC from patients, where only small biosamples are available, remains a challenge. In this study, we present a protocol to culture human SC from ~4-mm diagnostic sural nerve biopsies and a comprehensive transcriptome analysis to characterize their phenotype. Our protocol allows the reproducible establishment of cultures containing proliferative human Schwann cells that can be stored, expanded, and used as tools for diagnostic applications.
- Open Access
Sex differences define the molecular and cellular phenotypes of pain resolution in dorsal root ganglia
SUMMARY: The dorsal root ganglion (DRG), a key site for the initiation and maintenance of neuropathic pain, was examined for sex-dependent phenotypes in sensory neurons, satellite glial cells (SGCs), and local macrophages following traumatic nerve injury and during natural pain resolution. Systematic analysis of 7,495 DRG immunofluorescence images and 62 transcriptomes revealed pronounced sex-specific, multicellular DRG phenotypes, especially during pain resolution. System parameters, including tissue size and neuron density also showed sex-dependent differences. Neuropathic pain resolved without tissue or sensory neuron loss. After injury, macrophages invaded the space between sensory neurons and satellite glial cells (SGCs); this was partially reversed during pain resolution, particularly in males. In females, immune-related gene expression and macrophage phenotypes persisted longer, while SGC activation and contact to sensory neurons was more persistent in males. During resolution, synaptic and excitability-related processes were pronounced in both sexes. However, while injury responses were largely shared between sexes, the resolution phase displayed distinctly sex-specific molecular and cellular signatures. GRAPHICAL In brief: Analysis of ∼7,500 bioimages and 62 transcriptomes reveals pronounced sex differences in rat dorsal root ganglia during pain resolution after peripheral nerve injury. Highlights: In both female and male rats, peripheral nerve injury and subsequent pain resolution occur in the dorsal root ganglia (DRG) without neuronal or tissue loss. Sex influences DRG tissue size, neuron density, immune and glial phenotypes, and molecular-cellular responses to nerve injury and pain resolution. Following injury, macrophages infiltrate the space between sensory neurons and satellite glial cells (SGCs); this process reverses during pain resolution, particularly in males. In females, immune phenotypes remain more stable throughout pain resolution, while SGC contact is reduced. Pain resolution involves not only the reversal of injury-induced cell changes but also the activation of resolution-specific gene programs related to synaptic signaling, neuronal excitation, and cell–cell communication. Sex differences on the molecular-cellular level are less prevalent after nerve injury but become prominent during pain resolution.
Open AccessSex differences define the molecular and cellular phenotypes of pain resolution in dorsal root ganglia
SUMMARY: The dorsal root ganglion (DRG), a key site for the initiation and maintenance of neuropathic pain, was examined for sex-dependent phenotypes in sensory neurons, satellite glial cells (SGCs), and local macrophages following traumatic nerve injury and during natural pain resolution. Systematic analysis of 7,495 DRG immunofluorescence images and 62 transcriptomes revealed pronounced sex-specific, multicellular DRG phenotypes, especially during pain resolution. System parameters, including tissue size and neuron density also showed sex-dependent differences. Neuropathic pain resolved without tissue or sensory neuron loss. After injury, macrophages invaded the space between sensory neurons and satellite glial cells (SGCs); this was partially reversed during pain resolution, particularly in males. In females, immune-related gene expression and macrophage phenotypes persisted longer, while SGC activation and contact to sensory neurons was more persistent in males. During resolution, synaptic and excitability-related processes were pronounced in both sexes. However, while injury responses were largely shared between sexes, the resolution phase displayed distinctly sex-specific molecular and cellular signatures. GRAPHICAL In brief: Analysis of ∼7,500 bioimages and 62 transcriptomes reveals pronounced sex differences in rat dorsal root ganglia during pain resolution after peripheral nerve injury. Highlights: In both female and male rats, peripheral nerve injury and subsequent pain resolution occur in the dorsal root ganglia (DRG) without neuronal or tissue loss. Sex influences DRG tissue size, neuron density, immune and glial phenotypes, and molecular-cellular responses to nerve injury and pain resolution. Following injury, macrophages infiltrate the space between sensory neurons and satellite glial cells (SGCs); this process reverses during pain resolution, particularly in males. In females, immune phenotypes remain more stable throughout pain resolution, while SGC contact is reduced. Pain resolution involves not only the reversal of injury-induced cell changes but also the activation of resolution-specific gene programs related to synaptic signaling, neuronal excitation, and cell–cell communication. Sex differences on the molecular-cellular level are less prevalent after nerve injury but become prominent during pain resolution.
- Open Access
- 3 April 2024
- Published by Springer Nature in Research Square
Molecular and cellular processes of deafferentation after plexus injury in human dorsal root ganglia
Plexus injury results in lifelong suffering from flaccid paralysis, sensory loss, and intractable pain. For this clinical problem, regenerative medicine concepts set high expectations. However, it is completely unknown how dorsal root ganglia (DRG) are affected by accidental deafferentation. Here, we investigated human DRG in a clinically characterized cohort of patients with plexus injury. Avulsed DRG from 13 patients were collected during reconstructive nerve surgery. DRG were analyzed using large-scale microscopy, deep learning-based bioimage analysis, and RNA fragment sequencing of histopathological slices. In about half of the patients, we found a complete loss of DRG units consisting of neurons, satellite glial cells (SGC), and macrophages. The DRG cells were replaced by mesodermal/connective tissue. In the other half of the patients, the cellular units were well preserved and we found no gliosis and no significant neuronal loss. Furthermore, the expression of subtype-specific sensory neuron marker genes was preserved. However, downregulation of neuronal attributes associated with ion transport, synapses, and neuronal projection indicated a dormant neuronal phenotype. Injured DRG showed signs of ongoing inflammation and connective tissue remodeling. Patients with ‘neuronal preservation’ had less pain than patients with ‘neuronal loss’. Arm function improved after the nerve reconstruction, but the pain phenotype did not. With this study, we call for early intervention after injury to protect the DRG from complete cell loss. Pain patients may benefit from anti-inflammatory therapy. Future regenerative medicine concepts will need at least two translational directions: reafferentation of existing DRG units or replacement of the entire DRG.
- 3 April 2024
- Published by Springer Nature in Research Square
Open AccessMolecular and cellular processes of deafferentation after plexus injury in human dorsal root ganglia
Plexus injury results in lifelong suffering from flaccid paralysis, sensory loss, and intractable pain. For this clinical problem, regenerative medicine concepts set high expectations. However, it is completely unknown how dorsal root ganglia (DRG) are affected by accidental deafferentation. Here, we investigated human DRG in a clinically characterized cohort of patients with plexus injury. Avulsed DRG from 13 patients were collected during reconstructive nerve surgery. DRG were analyzed using large-scale microscopy, deep learning-based bioimage analysis, and RNA fragment sequencing of histopathological slices. In about half of the patients, we found a complete loss of DRG units consisting of neurons, satellite glial cells (SGC), and macrophages. The DRG cells were replaced by mesodermal/connective tissue. In the other half of the patients, the cellular units were well preserved and we found no gliosis and no significant neuronal loss. Furthermore, the expression of subtype-specific sensory neuron marker genes was preserved. However, downregulation of neuronal attributes associated with ion transport, synapses, and neuronal projection indicated a dormant neuronal phenotype. Injured DRG showed signs of ongoing inflammation and connective tissue remodeling. Patients with ‘neuronal preservation’ had less pain than patients with ‘neuronal loss’. Arm function improved after the nerve reconstruction, but the pain phenotype did not. With this study, we call for early intervention after injury to protect the DRG from complete cell loss. Pain patients may benefit from anti-inflammatory therapy. Future regenerative medicine concepts will need at least two translational directions: reafferentation of existing DRG units or replacement of the entire DRG.
- 9 June 2022
- Published by Taylor & Francis in Mycologia
- Vol. 114 (4) , 682-696
Fusarium abutilonisandF. guadeloupense, two novel species in theFusarium buharicumclade supported by multilocus molecular phylogenetic analyses
This study was conducted to elucidate evolutionary relationships and species diversity within the Fusarium buharicum species complex (FBSC). We also evaluate the potential of these species to produce mycotoxins and other bioactive secondary metabolites. Maximum likelihood and maximum parsimony analyses of sequences from portions of four marker loci (ITS rDNA, TEF1, RPB1, and RPB2) and the combined 4495 bp data set support recognition of seven genealogically exclusive species within the FBSC. Two of the three newly discovered species are formally described as F. abutilonis and F. guadeloupense based on concordance of gene genealogies and morphological data. Fusarium abutilonis induces leaf, stem, and root lesions on several weedy Malvaceae (Abution theophrasti, Anoda cristata, Sida spinosa) and a fabaceous host (Senna obtusifolia) in North America and also was recovered from soil in New Caledonia. Fusarium abutilonis, together with its unnamed sister, Fusarium sp. ex common marsh mallow (Hibiscus moscheutos) from Washington state, and F. buharicum pathogenic to cotton and kenaf in Russia and Iran, respectively, were strongly supported as a clade of malvaceous pathogens. The four other species of the FBSC are not known to be phytopathogenic; however, F. guadeloupense was isolated from human blood in Texas and soil in Guadeloupe. The former isolate is unique because it represents the only known case of a fusarial infection disseminated hematogenously by a species lacking microconidia and the only documented fusariosis caused by a member of the FBSC. Whole genome sequence data and extracts of cracked maize kernel cultures were analyzed to assess the potential of FBSC isolates to produce mycotoxins, pigments, and phytohormones.
- 9 June 2022
- Published by Taylor & Francis in Mycologia
- Vol. 114 (4) , 682-696
Fusarium abutilonisandF. guadeloupense, two novel species in theFusarium buharicumclade supported by multilocus molecular phylogenetic analyses
This study was conducted to elucidate evolutionary relationships and species diversity within the Fusarium buharicum species complex (FBSC). We also evaluate the potential of these species to produce mycotoxins and other bioactive secondary metabolites. Maximum likelihood and maximum parsimony analyses of sequences from portions of four marker loci (ITS rDNA, TEF1, RPB1, and RPB2) and the combined 4495 bp data set support recognition of seven genealogically exclusive species within the FBSC. Two of the three newly discovered species are formally described as F. abutilonis and F. guadeloupense based on concordance of gene genealogies and morphological data. Fusarium abutilonis induces leaf, stem, and root lesions on several weedy Malvaceae (Abution theophrasti, Anoda cristata, Sida spinosa) and a fabaceous host (Senna obtusifolia) in North America and also was recovered from soil in New Caledonia. Fusarium abutilonis, together with its unnamed sister, Fusarium sp. ex common marsh mallow (Hibiscus moscheutos) from Washington state, and F. buharicum pathogenic to cotton and kenaf in Russia and Iran, respectively, were strongly supported as a clade of malvaceous pathogens. The four other species of the FBSC are not known to be phytopathogenic; however, F. guadeloupense was isolated from human blood in Texas and soil in Guadeloupe. The former isolate is unique because it represents the only known case of a fusarial infection disseminated hematogenously by a species lacking microconidia and the only documented fusariosis caused by a member of the FBSC. Whole genome sequence data and extracts of cracked maize kernel cultures were analyzed to assess the potential of FBSC isolates to produce mycotoxins, pigments, and phytohormones.
- Open Access
- 8 November 2021
- Published by Elsevier in Antiviral Research
- Vol. 196, 105206
Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies
- 8 November 2021
- Published by Elsevier in Antiviral Research
- Vol. 196, 105206
Open AccessDevelopment and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies